You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gynecological Cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Philadelphia (OTL38, intraoperative imaging camera system)

Withdrawn
  • Ovarian Cancer
  • OTL38
  • intraoperative imaging camera system
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 23, 2022

Colon Cancer Trial in San Antonio (PalloV-CC)

Recruiting
  • Colon Cancer
  • PalloV-CC
  • San Antonio, Texas
    Clinical Associates of Research Therapeutics of America
Sep 14, 2022

Gynecology Trial in Houston (drug, other, procedure, behavioral)

Active, not recruiting
  • Gynecology
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 14, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Active, not recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +18 more
Feb 14, 2022

Breast Cancer Trial in United States (Capecitabine, Neratinib, EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30)

Active, not recruiting
  • Breast Cancer
  • Hartford, Connecticut
  • +9 more
Apr 15, 2022

Esophageal Cancer Trial in Rotterdam (Nivolumab)

Not yet recruiting
  • Esophageal Cancer
  • Rotterdam, Netherlands
    Erasmus MC
Aug 4, 2022

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Mar 29, 2022

Social Experiences of Adolescents and Young Adults With Cancer

Recruiting
  • Childhood Cancer
  • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 1, 2022

    Advanced Kidney Cancer Trial in Tianjin (Tislelizumab Lenvatinib)

    Recruiting
    • Advanced Kidney Cancer
    • Tislelizumab Lenvatinib
    • Tianjin, Tianjin, China
      Changyi Quan
    Aug 4, 2022

    Desmoid Trial in Zhengzhou (Anlotinib)

    Not yet recruiting
    • Desmoid
    • Zhengzhou, Henan, China
      Department of Bone and Soft Tissue ,Henan Cancer Hospital
    Aug 4, 2022

    Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

    Completed
    • Metastatic Breast Cancer
    • Breast Neoplasms
    • New York, New York
      Pfizer Inc.
    Aug 5, 2022

    Breast Cancer Trial in Lagos (mHealth psychoeducational intervention)

    Not yet recruiting
    • Breast Cancer
    • mHealth psychoeducational intervention
    • Lagos, Nigeria
    • +1 more
    Aug 4, 2022

    Bladder Cancer Trial in Vandœuvre-lès-Nancy (Urine collection (150ml), Blood sample (20 ml))

    Recruiting
    • Bladder Cancer
    • Urine collection (150ml)
    • Blood sample (20 ml)
    • Vandœuvre-lès-Nancy, France
      Institut de Cancérologie de Lorraine
    Mar 23, 2022

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Duarte, California
    • +2 more
    Oct 7, 2022

    Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)

    Recruiting
    • Locally Advanced Pancreatic Cancer
    • Washington, District of Columbia
    • +1 more
    Oct 10, 2022

    Ovarian Cancer Trial in New York (90Y-hu3S193, 111In-hu3S193)

    Completed
    Has Results
    • Ovarian Cancer
    • 90Y-hu3S193
    • 111In-hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Esophageal Cancer, Esophagogastric Junction Cancer Trial in Lexington (drug, radiation, procedure)

    Not yet recruiting
    • Esophageal Cancer
    • Esophagogastric Junction Cancer
    • Intravenous Tislelizumab
    • +3 more
    • Lexington, Kentucky
      University of Kentucky
    Feb 21, 2022

    Prostate Cancer Recurrent Trial in Tuebingen (CC-1 Infusion)

    Recruiting
    • Prostate Cancer Recurrent
    • CC-1 Infusion
    • Tuebingen, Germany
      University Hospital Tuebingen
    Jan 10, 2023

    Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)

    Approved for marketing
    • Prostatic Neoplasms
    • +4 more
    • 68GA PSMA-HBED-CC
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Mar 11, 2022

    CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

    Recruiting
    • CAR T-Cell Therapy
    • HEC-016(0.5×10^6 CAR-T Cells)
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Luohu Hospital
    Mar 3, 2022

    Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

    Active, not recruiting
    • Ann Arbor Stage II Follicular Lymphoma
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 3, 2022

    Radiodermatitis, Breast Tumors, Side Effect Trial (Mepitel Film)

    Completed
    • Radiodermatitis
    • +2 more
    • Mepitel Film
    • (no location specified)
    Nov 14, 2023

    NSCLC Trial in Changchun (Almonertinib, Placebo Almonertinib)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Changchun, Jilin, China
      Jilin Province Cancer Hospital
    Jun 13, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

    Recruiting
    • Ovarian Cancer
    • +5 more
    • TTI-622
    • Pegylated Liposomal Doxorubicin
    • Santa Monica, California
    • +4 more
    Jul 26, 2022

    Colorectal Cancer Trial in Rotterdam (Personalized screening invitation interval)

    Not yet recruiting
    • Colorectal Cancer
    • Personalized screening invitation interval
    • Rotterdam, Netherlands
      ErasmusMC
    Jun 14, 2022